Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamide.
Singletary E, Lieberman R, Atkinson N, Sneige N, Sahin A, Tolley S, Colchin M, Bevers T, Stelling C, Fornage B, Fritsche H, Hittelman W, Kelloff G, Lippman SM. Singletary E, et al. Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1087-90. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11045792 Clinical Trial.
Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N. Fisher B, et al. Among authors: bevers tb. J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62. doi: 10.1093/jnci/dji372. J Natl Cancer Inst. 2005. PMID: 16288118 Clinical Trial.
Breast cancer screening and diagnosis.
Bevers TB, Anderson BO, Bonaccio E, Borgen PI, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Helvie M, Hoover S, Krontiras H, Shaw S, Singletary E, Sugg Skinner C, Smith ML, Tsangaris TN, Wiley EL, Williams C; National Comprehensive Cancer Network. Bevers TB, et al. J Natl Compr Canc Netw. 2006 May;4(5):480-508. doi: 10.6004/jnccn.2006.0040. J Natl Compr Canc Netw. 2006. PMID: 16687096 No abstract available.
Raloxifene and the prevention of breast cancer.
Bevers TB. Bevers TB. Expert Opin Pharmacother. 2006 Nov;7(16):2301-7. doi: 10.1517/14656566.7.16.2301. Expert Opin Pharmacother. 2006. PMID: 17059385 Review.
Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged <or=55 years.
Lu J, Wei Q, Bondy ML, Brewster AM, Bevers TB, Yu TK, Buchholz TA, Meric-Bernstam F, Hunt KK, Singletary SE, Wang LE. Lu J, et al. Among authors: bevers tb. Breast Cancer Res Treat. 2008 Jul;110(2):357-66. doi: 10.1007/s10549-007-9717-2. Epub 2007 Sep 13. Breast Cancer Res Treat. 2008. PMID: 17851762 Free PMC article.
Breast cancer risk reduction.
Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Lawton T, Loftus L, Macdonald DJ, Mahoney MC, Merajver SD, Seewaldt V, Sellin RV, Shapiro CL, Singletary E, Ward JH; National Comprehensive Cancer Network (NCCN). Bevers TB, et al. J Natl Compr Canc Netw. 2007 Sep;5(8):676-701. J Natl Compr Canc Netw. 2007. PMID: 17927926 No abstract available.
97 results